India revokes yet another pharmaceutical patent owned by a foreign multinational, with Merck (NYSE:MRK) losing protection for an asthma treatment after domestic drug-maker Cipla challenged an earlier decision. Pfizer, Roche and Novartis are among those to have experienced patent trouble in the country. (previous)
India revokes yet another pharmaceutical patent owned by a foreign multinational, with Merck...
Recommended For You
About MRK Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MRK | - | - |
Merck & Co., Inc. |